NS · Pharmaceuticals

Mankind Pharma Ltd (MANKIND)

Pharmaceuticals & Biotechnology

Mankind Pharma Ltd (MANKIND) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $1.05T, P/E ratio is 51.33, net margin is 19.2%, dividend yield is 0.04%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MANKIND

Market cap

$1.05T

P/E ratio

51.33

Net margin

19.2%

Dividend yield

0.04%

Mankind Pharma Ltd (MANKIND) — FAQ

What is Mankind Pharma Ltd's market cap?

Mankind Pharma Ltd (MANKIND) has a reported market cap of $1.05T (data as of 2026-07-10).

What is MANKIND's P/E ratio?

The price-to-earnings (P/E) ratio for Mankind Pharma Ltd (MANKIND) is 51.33 (data as of 2026-07-10).

Does Mankind Pharma Ltd pay a dividend?

Mankind Pharma Ltd (MANKIND) shows a reported dividend yield of 0.04%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Mankind Pharma Ltd in?

Mankind Pharma Ltd (MANKIND) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is MANKIND listed on?

MANKIND is listed on NS.

What is Mankind Pharma Ltd's net margin?

Mankind Pharma Ltd (MANKIND) reports a net margin of 19.2% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)